$CBUS
Cibus, Inc.

2022 Q4 Form 10-Q Financial Statement

#000119312522276921 Filed on November 03, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $42.00K $42.00K $7.762M
YoY Change -97.84% -99.46% 48.1%
Cost Of Revenue $0.00 $0.00 $8.281M
YoY Change -100.0% -100.0% 17.29%
Gross Profit $42.00K $42.00K -$519.0K
YoY Change -168.85% -108.09% -71.47%
Gross Profit Margin 100.0% 100.0% -6.69%
Selling, General & Admin $1.009M $3.229M $3.859M
YoY Change -73.36% -16.33% -14.68%
% of Gross Profit 2402.38% 7688.1%
Research & Development $2.346M $3.016M $2.579M
YoY Change -18.03% 16.94% 17.01%
% of Gross Profit 5585.71% 7180.95%
Depreciation & Amortization $376.0K $395.0K $596.0K
YoY Change -33.1% -33.72% 26.81%
% of Gross Profit 895.24% 940.48%
Operating Expenses $3.355M $6.245M $6.438M
YoY Change -49.54% -3.0% -10.97%
Operating Profit -$3.313M -$6.203M -$6.957M
YoY Change -50.63% -10.84% -23.13%
Interest Expense $476.0K $57.00K $356.0K
YoY Change -237.18% -83.99% -3.52%
% of Operating Profit
Other Income/Expense, Net $300.0K $6.000K
YoY Change 4900.0% -105.88%
Pretax Income -$2.837M -$5.950M -$7.307M
YoY Change -59.8% -18.57% -22.89%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$2.837M -$5.950M -$7.307M
YoY Change -59.8% -18.57% -22.89%
Net Earnings / Revenue -6754.76% -14166.67% -94.14%
Basic Earnings Per Share -$0.13 -$0.20
Diluted Earnings Per Share -$0.06 -$0.13 -$196.0K
COMMON SHARES
Basic Shares Outstanding 48.84M 46.79M 37.27M
Diluted Shares Outstanding 46.78M 37.28M

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.427M $7.031M $13.92M
YoY Change -75.21% -49.5% -50.28%
Cash & Equivalents $3.427M $7.031M $13.92M
Short-Term Investments $0.00
Other Short-Term Assets $705.0K $913.0K $1.450M
YoY Change -48.09% -37.03% -23.68%
Inventory $1.674M
Prepaid Expenses $210.0K
Receivables $0.00 $206.0K
Other Receivables $0.00
Total Short-Term Assets $4.132M $7.944M $17.25M
YoY Change -72.78% -53.95% -54.96%
LONG-TERM ASSETS
Property, Plant & Equipment $4.516M $4.859M $21.48M
YoY Change -79.22% -77.37% -5.81%
Goodwill $0.00
YoY Change
Intangibles $158.0K
YoY Change
Long-Term Investments
YoY Change
Other Assets $158.0K $163.0K $195.0K
YoY Change -13.66% -16.41% -86.07%
Total Long-Term Assets $18.29M $18.76M $22.27M
YoY Change -16.92% -15.77% -7.98%
TOTAL ASSETS
Total Short-Term Assets $4.132M $7.944M $17.25M
Total Long-Term Assets $18.29M $18.76M $22.27M
Total Assets $22.42M $26.70M $39.52M
YoY Change -39.72% -32.44% -36.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $340.0K $435.0K $1.037M
YoY Change -73.02% -58.05% -13.58%
Accrued Expenses $173.0K $380.0K $1.139M
YoY Change -48.97% -66.64% -80.69%
Deferred Revenue $107.0K
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $97.00K $120.0K $387.0K
YoY Change -73.78% -68.99% -3.25%
Total Short-Term Liabilities $1.700M $4.200M $5.100M
YoY Change -64.98% -17.65% -35.44%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $79.00K $80.00K $971.0K
YoY Change -88.75% -91.76% 871.0%
Total Long-Term Liabilities $79.00K $80.00K $971.0K
YoY Change -88.75% -91.76% -95.05%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.700M $4.200M $5.100M
Total Long-Term Liabilities $79.00K $80.00K $971.0K
Total Liabilities $15.19M $17.86M $23.70M
YoY Change -34.14% -24.64% -14.14%
SHAREHOLDERS EQUITY
Retained Earnings -$212.2M -$209.3M -$189.0M
YoY Change 8.19% 10.75%
Common Stock $220.4M $219.2M $205.9M
YoY Change 4.34% 6.46%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $7.233M $8.800M $15.83M
YoY Change
Total Liabilities & Shareholders Equity $22.42M $26.70M $39.52M
YoY Change -39.72% -32.44% -36.77%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$2.837M -$5.950M -$7.307M
YoY Change -59.8% -18.57% -22.89%
Depreciation, Depletion And Amortization $376.0K $395.0K $596.0K
YoY Change -33.1% -33.72% 26.81%
Cash From Operating Activities -$3.763M -$4.325M -$3.405M
YoY Change -9.48% 27.02% -36.24%
INVESTING ACTIVITIES
Capital Expenditures $11.00K -$220.0K -$69.00K
YoY Change -109.09% 218.84% -89.05%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$11.00K -$220.0K -$69.00K
YoY Change -90.91% 218.84% -100.81%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 95.00K -164.0K -93.00K
YoY Change -97.49% 76.34% -177.5%
NET CHANGE
Cash From Operating Activities -3.763M -4.325M -3.405M
Cash From Investing Activities -11.00K -220.0K -69.00K
Cash From Financing Activities 95.00K -164.0K -93.00K
Net Change In Cash -3.679M -4.709M -3.567M
YoY Change 647.76% 32.02% -208.42%
FREE CASH FLOW
Cash From Operating Activities -$3.763M -$4.325M -$3.405M
Capital Expenditures $11.00K -$220.0K -$69.00K
Free Cash Flow -$3.774M -$4.105M -$3.336M
YoY Change -6.49% 23.05% -29.17%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001705843
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Address State Or Province
EntityAddressStateOrProvince
MN
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38161
dei Entity Registrant Name
EntityRegistrantName
Calyxt, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-1967997
dei Entity Address Address Line1
EntityAddressAddressLine1
2800 Mount Ridge Road
dei Entity Address City Or Town
EntityAddressCityOrTown
Roseville
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
55113-1127
dei City Area Code
CityAreaCode
651
dei Local Phone Number
LocalPhoneNumber
683-2807
dei Security12b Title
Security12bTitle
Common Stock (0.0001 par value)
dei Trading Symbol
TradingSymbol
CLXT
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
48841286
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7031000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13823000
CY2022Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
174000
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
499000
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
739000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
859000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1528000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1158000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
271000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
227000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9894000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-44000
CY2022Q3 us-gaap Assets Current
AssetsCurrent
7944000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
15181000
CY2022Q3 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
0
CY2021Q4 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
99000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4859000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21731000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
13736000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
163000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
183000
CY2022Q3 us-gaap Assets
Assets
26702000
CY2021Q4 us-gaap Assets
Assets
37194000
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
435000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1260000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
380000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
339000
CY2022Q3 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
2356000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1776000
CY2021Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
2522000
CY2022Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
138000
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
172000
CY2022Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
120000
CY2021Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
370000
CY2022Q3 clxt Common Stock Warrants Current
CommonStockWarrantsCurrent
402000
CY2021Q4 clxt Common Stock Warrants Current
CommonStockWarrantsCurrent
0
us-gaap Share Based Compensation
ShareBasedCompensation
2890000
CY2022Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
397000
us-gaap Share Based Compensation
ShareBasedCompensation
865000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
191000
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
4228000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4854000
CY2022Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
0
CY2022Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-47000
CY2021Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
17506000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
13550000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
80000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
702000
CY2021Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-356000
CY2022Q3 us-gaap Liabilities
Liabilities
17858000
CY2021Q4 us-gaap Liabilities
Liabilities
23062000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-80000
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1059000
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
275000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
275000000
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
46909420
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
300000
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
46809268
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
38874146
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5083000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
11000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
38773994
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
5000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
4000
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
219196000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
211263000
CY2022Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
100152
CY2021Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
100152
CY2022Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
1043000
CY2021Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
1043000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.12
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-209314000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
420606
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
7.05
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-196092000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
8844000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
14132000
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
26702000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
37194000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
42000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5950000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7762000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
115000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
24044000
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8281000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
26553000
CY2022Q3 us-gaap Gross Profit
GrossProfit
42000
CY2021Q3 us-gaap Gross Profit
GrossProfit
-519000
us-gaap Gross Profit
GrossProfit
115000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7307000
us-gaap Gross Profit
GrossProfit
-2509000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3016000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2579000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9207000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8473000
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3229000
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3859000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
9965000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11640000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
6245000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
6438000
us-gaap Operating Expenses
OperatingExpenses
19172000
us-gaap Operating Expenses
OperatingExpenses
20113000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-6203000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14054000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-22142000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-6957000
us-gaap Operating Income Loss
OperatingIncomeLoss
-19057000
us-gaap Operating Income Loss
OperatingIncomeLoss
-22622000
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1528000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-5950000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-7307000
us-gaap Net Income Loss
NetIncomeLoss
-14054000
us-gaap Net Income Loss
NetIncomeLoss
-22142000
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.2
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.2
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.31
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.31
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.6
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.6
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46784445
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46784445
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37279703
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37279703
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45173455
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45173455
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37205655
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37205655
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15997260
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5966488
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15997260
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5966488
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
13759000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-5950000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1035000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
8844000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
21896000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-7307000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1236000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
15825000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
14132000
us-gaap Net Income Loss
NetIncomeLoss
-14054000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2890000
clxt Cumulative Effect Of Adoption Of Lease Accounting Standard
CumulativeEffectOfAdoptionOfLeaseAccountingStandard
832000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
8844000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
36875000
us-gaap Net Income Loss
NetIncomeLoss
-22142000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
865000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
15825000
us-gaap Profit Loss
ProfitLoss
-14054000
us-gaap Profit Loss
ProfitLoss
-22142000
clxt Unrealized Gain Loss On Marktomarket Of Common Stock Warrants
UnrealizedGainLossOnMarktomarketOfCommonStockWarrants
-5009000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4681000
clxt Increase Decrease In Due To From Related Parties Current
IncreaseDecreaseInDueToFromRelatedPartiesCurrent
-34000
clxt Increase Decrease In Due To From Related Parties Current
IncreaseDecreaseInDueToFromRelatedPartiesCurrent
-617000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
291000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-297000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2873000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-188000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
108000
clxt Increase Decrease In Accrued Expenses
IncreaseDecreaseInAccruedExpenses
41000
clxt Increase Decrease In Accrued Expenses
IncreaseDecreaseInAccruedExpenses
-1742000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-166000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
334000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
536000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-1029000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15601000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14654000
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
11698000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1509000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
376000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1509000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
11322000
clxt Proceeds From The Issuance Of Common Stock And Pre Funded Warrants
ProceedsFromTheIssuanceOfCommonStockAndPreFundedWarrants
11209000
clxt Payments Of Stock And Warrants Issuance Costs
PaymentsOfStockAndWarrantsIssuanceCosts
962000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
353000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-7216000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3376000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14421000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18289000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7205000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14913000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.47
CY2022Q3 clxt Land Buildings And Equipment And Operating Lease Right Of Use Asset Lessee
LandBuildingsAndEquipmentAndOperatingLeaseRightOfUseAssetLessee
18600000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
8800000
CY2022Q3 clxt Market Capitalization Of Stockholders Equity
MarketCapitalizationOfStockholdersEquity
8000000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
us-gaap Net Income Loss
NetIncomeLoss
-14100000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15600000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7200000
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
100000
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
4200000
CY2022Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
3880000
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10000000
CY2022Q1 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
900000
CY2022Q3 us-gaap Other Liabilities Fair Value Disclosure
OtherLiabilitiesFairValueDisclosure
402000
CY2022Q3 clxt Estimated Fair Value Of Common Warrants Measurement Input
EstimatedFairValueOfCommonWarrantsMeasurementInput
0.05
CY2021Q4 clxt Finance Lease Obligations Fair Value Disclosure
FinanceLeaseObligationsFairValueDisclosure
14500000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1609000
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
2712803
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2789110
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
10.23
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4658405
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3314828
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
9.88
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5846799
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.35
CY2022Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
CY2021Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
227000
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
344000
CY2022Q3 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
13734000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1480000
CY2022Q3 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
0
CY2022Q3 clxt Operating And Finance Lease Liabilities Payments Next Two Years
OperatingAndFinanceLeaseLiabilitiesPaymentsNextTwoYears
1480000
CY2022Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1479000
CY2022Q3 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
0
CY2022Q3 clxt Finance Lease Cost
FinanceLeaseCost
57000
clxt Finance Lease Cost
FinanceLeaseCost
73000
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
381000
us-gaap Operating Lease Cost
OperatingLeaseCost
1174000
CY2022Q3 us-gaap Variable Lease Cost
VariableLeaseCost
260000
us-gaap Variable Lease Cost
VariableLeaseCost
717000
CY2022Q3 us-gaap Lease Cost
LeaseCost
698000
us-gaap Lease Cost
LeaseCost
1964000
clxt Payment Of Operating Lease Included In Operating Cash Flow
PaymentOfOperatingLeaseIncludedInOperatingCashFlow
205000
clxt Payment Of Finance Lease Included In Operating Cash Flow
PaymentOfFinanceLeaseIncludedInOperatingCashFlow
0
clxt Payment Of Operating Lease Included In Financing Cash Flow
PaymentOfOperatingLeaseIncludedInFinancingCashFlow
0
clxt Payment Of Finance Lease Included In Financing Cash Flow
PaymentOfFinanceLeaseIncludedInFinancingCashFlow
353000
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P15Y7M6D
CY2022Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P0Y7M6D
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.079
CY2022Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.081
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
345000
CY2022Q3 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
25000
CY2022Q3 clxt Operating And Finance Lease Liabilities Payments Remainder Of Fiscal Year
OperatingAndFinanceLeaseLiabilitiesPaymentsRemainderOfFiscalYear
370000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1446000
CY2022Q3 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
100000
CY2022Q3 clxt Operating And Finance Lease Liabilities Payments Next Twelve Months
OperatingAndFinanceLeaseLiabilitiesPaymentsNextTwelveMonths
1546000
CY2022Q3 clxt Operating And Finance Lease Liabilities Payments Next Three Years
OperatingAndFinanceLeaseLiabilitiesPaymentsNextThreeYears
1479000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1479000
CY2022Q3 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
0
CY2022Q3 clxt Operating And Finance Lease Liabilities Payments Next Four Years
OperatingAndFinanceLeaseLiabilitiesPaymentsNextFourYears
1479000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1479000
CY2022Q3 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
0
CY2022Q3 clxt Operating And Finance Lease Liabilities Payments Next Five Years
OperatingAndFinanceLeaseLiabilitiesPaymentsNextFiveYears
1479000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
16991000
CY2022Q3 us-gaap Finance Lease Liability Payments Due After Year Five
FinanceLeaseLiabilityPaymentsDueAfterYearFive
0
CY2022Q3 clxt Operating And Finance Lease Liabilities Payments After Five Years
OperatingAndFinanceLeaseLiabilitiesPaymentsAfterFiveYears
16991000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
24699000
CY2022Q3 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
125000
CY2022Q3 clxt Operating And Finance Lease Liability Payment Due
OperatingAndFinanceLeaseLiabilityPaymentDue
24824000
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
10814000
CY2022Q3 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
5000
CY2022Q3 clxt Operating And Finance Lease Liability Undiscounted Excess Amount
OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount
10819000
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
13885000
CY2022Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
120000
CY2022Q3 clxt Lessee Operating And Finance Lease Liability
LesseeOperatingAndFinanceLeaseLiability
14005000
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1035000
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1236000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2890000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
865000
CY2022Q3 us-gaap Interest Expense
InterestExpense
57000
CY2021Q3 us-gaap Interest Expense
InterestExpense
356000
us-gaap Interest Expense
InterestExpense
73000
us-gaap Interest Expense
InterestExpense
1075000
CY2022Q3 us-gaap Investment Income Net
InvestmentIncomeNet
31000
CY2021Q3 us-gaap Investment Income Net
InvestmentIncomeNet
0
us-gaap Investment Income Net
InvestmentIncomeNet
44000
us-gaap Investment Income Net
InvestmentIncomeNet
16000
CY2022Q3 clxt Common Warrants Financing Costs
CommonWarrantsFinancingCosts
-21000
CY2021Q3 clxt Common Warrants Financing Costs
CommonWarrantsFinancingCosts
0
clxt Common Warrants Financing Costs
CommonWarrantsFinancingCosts
-51000
clxt Common Warrants Financing Costs
CommonWarrantsFinancingCosts
0
CY2022Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-47000
CY2021Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-356000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-80000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1059000
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7031000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13823000
CY2022Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
174000
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
499000
CY2022Q3 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
0
CY2021Q4 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
99000
CY2022Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
7205000
CY2021Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
14421000
us-gaap Interest Paid
InterestPaid
67000
us-gaap Interest Paid
InterestPaid
1072000
clxt Receivable From Jefferies For Shares Issued Under Atm Facility
ReceivableFromJefferiesForSharesIssuedUnderAtmFacility
-260000
clxt Receivable From Jefferies For Shares Issued Under Atm Facility
ReceivableFromJefferiesForSharesIssuedUnderAtmFacility
0
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
687000
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
0
clxt Cumulative Effect Of Adoption Of Lease Accounting Standard On Stockholders Equity
CumulativeEffectOfAdoptionOfLeaseAccountingStandardOnStockholdersEquity
832000
clxt Cumulative Effect Of Adoption Of Lease Accounting Standard On Stockholders Equity
CumulativeEffectOfAdoptionOfLeaseAccountingStandardOnStockholdersEquity
0
clxt Establishment Of Right To Use Assets And Associated Operating Lease Liabilities.
EstablishmentOfRightToUseAssetsAndAssociatedOperatingLeaseLiabilities.
14090000
clxt Establishment Of Right To Use Assets And Associated Operating Lease Liabilities.
EstablishmentOfRightToUseAssetsAndAssociatedOperatingLeaseLiabilities.
0
CY2022Q4 us-gaap Litigation Settlement Amount Awarded From Other Party
LitigationSettlementAmountAwardedFromOtherParty
750000

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001193125-22-276921-index-headers.html Edgar Link pending
0001193125-22-276921-index.html Edgar Link pending
0001193125-22-276921.txt Edgar Link pending
0001193125-22-276921-xbrl.zip Edgar Link pending
clxt-20220930.xsd Edgar Link pending
d367991d10q.htm Edgar Link pending
clxt-20220930_lab.xml Edgar Link unprocessable
clxt-20220930_def.xml Edgar Link unprocessable
clxt-20220930_pre.xml Edgar Link unprocessable
clxt-20220930_cal.xml Edgar Link unprocessable
d367991d10q_htm.xml Edgar Link completed
d367991dex311.htm Edgar Link pending
d367991dex312.htm Edgar Link pending
d367991dex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g367991g1022051150796.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending